| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 11.163.971 $ | 96,91 | 647.313 | ||||||
| DEFINIUM THERAPEUTICS INC | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 344.991 $ | 2,99 | 7.334 | |
| MBX BIOSCIENCES INC | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 303.600 $ | 2,64 | 5.500 | |
| ALUMIS INC | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 239.106 $ | 2,08 | 8.497 | |
| ATAIBECKLEY INC | AtaiBeckley, Inc. | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 237.635 $ | 2,06 | 45.092 | |
| TREVI THERAPEUTICS INC | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 237.228 $ | 2,06 | 12.720 | |
| ENLIVEN THERAPEUTICS INC | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 233.805 $ | 2,03 | 4.607 | |
| AMYLYX PHARMACEUTICALS INC | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 227.427 $ | 1,97 | 12.663 | |
| VERADERMICS INC | VeraDermics, Inc. | EC | 922967104 | Long | Börsenkurs (Stufe 1) | 225.349 $ | 1,96 | 1.833 | |
| LIGAND PHARMACEUTICALS INC | Ligand Pharmaceuticals, Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 217.154 $ | 1,89 | 687 | |
| NUVATION BIO INC | Nuvation Bio, Inc. | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 211.387 $ | 1,84 | 37.216 | |
| EDGEWISE THERAPEUTICS INC | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 210.382 $ | 1,83 | 5.178 | |
| NEKTAR THERAPEUTICS | Nektar Therapeutics | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 209.570 $ | 1,82 | 3.002 | |
| LIQUIDIA CORP | Liquidia Corporation | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 208.255 $ | 1,81 | 2.612 | |
| MAZE THERAPEUTICS INC | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 206.791 $ | 1,80 | 6.930 | |
| HARROW INC | Harrow, Inc. | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 201.648 $ | 1,75 | 4.748 | |
| EYEPOINT INC | EyePoint Pharmaceuticals, Inc. | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 197.683 $ | 1,72 | 13.824 | |
| AMNEAL PHARMACEUTICALS INC | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 192.591 $ | 1,67 | 11.126 | |
| OCULAR THERAPEUTIX INC | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 191.510 $ | 1,66 | 19.502 | |
| CORCEPT THERAPEUTICS INC | Corcept Therapeutics, Inc. | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 189.725 $ | 1,65 | 2.182 | |
| CRINETICS PHARMACEUTICALS INC | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 185.790 $ | 1,61 | 4.965 | |
| PACIRA BIOSCIENCES INC | Pacira BioSciences, Inc. | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 184.643 $ | 1,60 | 7.278 | |
| MERCK & COMPANY INC | Merck & Company, Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 183.884 $ | 1,60 | 1.431 | |
| INDIVIOR PHARMACEUTICALS INC | Indivior Pharmaceuticals, Inc. | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 183.609 $ | 1,59 | 4.475 | |
| ELANCO ANIMAL HEALTH INC | Elanco Animal Health, Inc. | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 183.418 $ | 1,59 | 7.453 | |
| JOHNSON & JOHNSON | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 181.589 $ | 1,58 | 715 | |
| ELI LILLY & COMPANY | Eli Lilly & Company | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 179.915 $ | 1,56 | 150 | |
| JAZZ PHARMACEUTICALS PLC | Jazz Pharmaceuticals plc | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 178.800 $ | 1,55 | 742 | |
| COLLEGIUM PHARMACEUTICAL INC | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 177.308 $ | 1,54 | 4.898 | |
| BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb Company | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 176.663 $ | 1,53 | 3.066 | |
| SUPERNUS PHARMACEUTICALS INC | Supernus Pharmaceuticals, Inc. | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 175.808 $ | 1,53 | 3.780 | |
| ROYALTY PHARMA PLC | Royalty Pharma plc | EC | G7709Q104 | Long | Börsenkurs (Stufe 1) | 175.331 $ | 1,52 | 3.127 | |
| TARSUS PHARMACEUTICALS INC | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 175.099 $ | 1,52 | 2.782 | |
| WAVE LIFE SCIENCES LTD | WaVe Life Sciences Ltd. | EC | Y95308105 | Long | Börsenkurs (Stufe 1) | 174.968 $ | 1,52 | 30.115 | |
| HARMONY BIOSCIENCES HOLDINGS INC | Harmony Biosciences Holdings, Inc. | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 174.914 $ | 1,52 | 4.804 | |
| ANI PHARMACEUTICALS INC | ANI Pharmaceuticals, Inc. | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 172.514 $ | 1,50 | 2.084 | |
| ORGANON & COMPANY | Organon & Company | EC | 68622V106 | Long | Börsenkurs (Stufe 1) | 172.486 $ | 1,50 | 12.739 | |
| VIATRIS INC | Viatris, Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 171.631 $ | 1,49 | 10.808 | |
| ESPERION THERAPEUTICS INC | Esperion Therapeutics, Inc. | EC | 29664W105 | Long | Börsenkurs (Stufe 1) | 171.534 $ | 1,49 | 54.283 | |
| AXSOME THERAPEUTICS INC | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 169.381 $ | 1,47 | 692 | |
| INNOVIVA INC | Innoviva, Inc. | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 168.304 $ | 1,46 | 7.411 | |
| BIOAGE LABS INC | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 167.526 $ | 1,45 | 6.835 | |
| PRESTIGE CONSUMER HEALTHCARE INC | Prestige Consumer Healthcare, Inc. | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 163.980 $ | 1,42 | 3.469 | |
| RAPPORT THERAPEUTICS INC | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 160.638 $ | 1,39 | 3.855 | |
| PFIZER INC | Pfizer, Inc. | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 160.325 $ | 1,39 | 6.658 | |
| OMEROS CORP | Omeros Corporation | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 158.922 $ | 1,38 | 16.711 | |
| PERRIGO COMPANY PLC | Perrigo Company plc | EC | G97822103 | Long | Börsenkurs (Stufe 1) | 158.551 $ | 1,38 | 15.260 | |
| XERIS BIOPHARMA HOLDINGS INC | Xeris Biopharma Holdings, Inc. | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 155.549 $ | 1,35 | 19.640 | |
| ZOETIS INC | Zoetis, Inc. | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 150.690 $ | 1,31 | 2.097 | |
| ETON PHARMACEUTICALS INC | Eton Pharmaceuticals, Inc. | EC | 29772L108 | Long | Börsenkurs (Stufe 1) | 145.741 $ | 1,27 | 4.026 | |
| PHIBRO ANIMAL HEALTH CORP | Phibro Animal Health Corporation | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 143.435 $ | 1,25 | 4.568 | |
| AMPHASTAR PHARMACEUTICALS INC | Amphastar Pharmaceuticals, Inc. | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 139.747 $ | 1,21 | 6.925 | |
| ARVINAS INC | Arvinas, Inc. | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 139.292 $ | 1,21 | 16.762 | |
| ZEVRA THERAPEUTICS INC | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 138.094 $ | 1,20 | 9.630 | |
| ALTO NEUROSCIENCE INC | Alto Neuroscience Inc | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 130.868 $ | 1,14 | 4.959 | |
| PHATHOM PHARMACEUTICALS INC | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 118.742 $ | 1,03 | 10.944 | |
| RELMADA THERAPEUTICS INC | Relmada Therapeutics, Inc. | EC | 75955J402 | Long | Börsenkurs (Stufe 1) | 118.180 $ | 1,03 | 17.078 | |
| CORMEDIX INC | CorMedix, Inc. | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 112.522 $ | 0,98 | 14.334 | |
| SEPTERNA INC | Septerna, Inc. | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 110.617 $ | 0,96 | 3.303 | |
| THERAVANCE BIOPHARMA INC | Theravance Biopharma, Inc. | EC | G8807B106 | Long | Börsenkurs (Stufe 1) | 106.862 $ | 0,93 | 6.286 | |
| ACLARIS THERAPEUTICS INC | Aclaris Therapeutics, Inc. | EC | 00461U105 | Long | Börsenkurs (Stufe 1) | 99.843 $ | 0,87 | 18.874 | |
| LB PHARMACEUTICALS INC | LB Pharmaceuticals, Inc. | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 88.992 $ | 0,77 | 2.742 | |
| AQUESTIVE THERAPEUTICS INC | Aquestive Therapeutics, Inc. | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 85.426 $ | 0,74 | 20.535 | |
| FULCRUM THERAPEUTICS INC | Fulcrum Therapeutics, Inc. | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 77.061 $ | 0,67 | 21.055 | |
| LEXICON PHARMACEUTICALS INC | Lexicon Pharmaceuticals Inc | EC | 528872302 | Long | Börsenkurs (Stufe 1) | 70.205 $ | 0,61 | 29.252 | |
| EVOLUS INC | Evolus, Inc. | EC | 30052C107 | Long | Börsenkurs (Stufe 1) | 58.740 $ | 0,51 | 8.464 | |
| Gesamt | 11.163.971 $ | 96,91 | 647.313 |